These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15448581)

  • 41. [Drug therapy of anxiety states].
    Laux G
    Krankenpfl J; 1982 Feb; 20(2):22-4. PubMed ID: 6121084
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug treatment of anxiety.
    Cole JO
    South Med J; 1978 Aug; 71 Suppl 2():10-14. PubMed ID: 28569
    [No Abstract]   [Full Text] [Related]  

  • 43. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
    Pitsikas N
    Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conquering anxiety.
    Lavick J; Vaccaro G
    BETA; 2007; 19(2):20-8. PubMed ID: 17489113
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization and biological effects of Hypericum extracts on experimentally-induced - anxiety, oxidative stress and inflammation in rats.
    Sevastre-Berghian AC; Toma VA; Sevastre B; Hanganu D; Vlase L; Benedec D; Oniga I; Baldea I; Olteanu D; Moldovan R; Decea N; Filip GA; Clichici SV
    J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the anxiety phenomenology in psychotic prodrome: A case report.
    Kar SK; Shahi MK; Roy P
    Asian J Psychiatr; 2017 Aug; 28():88. PubMed ID: 28784406
    [No Abstract]   [Full Text] [Related]  

  • 47. [Psychopharmacology of anxiety. 1].
    Agressologie; 1981 Oct; 22(C):1-53. PubMed ID: 6119916
    [No Abstract]   [Full Text] [Related]  

  • 48. Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists.
    Hughes J; Hunter JC; Woodruff GN
    Neuropeptides; 1991 Jul; 19 Suppl():85-9. PubMed ID: 1679213
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of anxiety states].
    Rees L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(1):5-10. PubMed ID: 6104894
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of drugs for anxiety.
    Caster DU
    Rocky Mt Med J; 1977; 74(1):29-32. PubMed ID: 13475
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic drug monitoring of alprazolam in adolescents with asthma.
    DeVane CL; Hill M; Antal EJ
    Ther Drug Monit; 1998 Jun; 20(3):257-60. PubMed ID: 9631921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzodiazepines in the management of anxiety.
    Buchan T
    Cent Afr J Med; 1984 Mar; 30(3):297-8, 300. PubMed ID: 6143621
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of midazolam for refractory status epilepticus in pediatric patients.
    Pellock JM
    J Child Neurol; 1998 Dec; 13(12):581-7. PubMed ID: 9881528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy of anxiety. II. Minor tranquilizing agents and other substances].
    Messini M; Messini F
    Clin Ter; 1976 Jun; 77(6):509-27. PubMed ID: 12902
    [No Abstract]   [Full Text] [Related]  

  • 55. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.
    Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE
    Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of persistent anxiety and novel uses for anxiolytics.
    J Clin Psychiatry; 1996; 57 Suppl 7():3-95. PubMed ID: 8690695
    [No Abstract]   [Full Text] [Related]  

  • 57. Relief of anxiety during invasive diagnostic procedures.
    Hilton JI
    N Engl J Med; 1980 Mar; 302(13):754. PubMed ID: 6101902
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluating and treating anxiety disorders in medical settings.
    Ball S; Goddard A; Shekhar A
    J Postgrad Med; 2002; 48(4):317-21. PubMed ID: 12571395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Using of aphobazol in the treatment of adaptation disorder in the contract service men, dismissed from the armed forces].
    Litvintsev SV; Davydov AT; Uspenskiĭ IuP; Zagrebel'nyĭ IA; Balukova EV
    Voen Med Zh; 2007 Nov; 328(11):28-9. PubMed ID: 18306710
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical experiences with the use of indole-3-pyruvic acid.
    Politi V; De Luca G; Gallai V; Puca ; Comin M
    Adv Exp Med Biol; 1999; 467():227-32. PubMed ID: 10721060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.